|
Status |
Public on Oct 17, 2014 |
Title |
siYAP RNA #1 transfected, biological rep 3 |
Sample type |
RNA |
|
|
Source name |
Human umbilical vein endothelial cell
|
Organism |
Homo sapiens |
Characteristics |
treatment: siYAP RNA #1 transfected cell type: Primary cell line
|
Treatment protocol |
siRNA was synthesized as duplex by Life Technology and transfected directly using Invitrogen RNAiMAX. All steps were conducted according to the included vendor protocol.
|
Growth protocol |
Cells were cultured in culture dishes pre-coated with 0.1% gelatin with commercial EGM2 media from Lonza
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen miRNeasy kit was used for extraction
|
Label |
None
|
Label protocol |
standard Affymetrix protocol
|
|
|
Hybridization protocol |
standard Affymetrix protocol, performed by Penn Genomic Analysis Core
|
Scan protocol |
standard Affymetrix protocol, performed by Penn Genomic Analysis Core
|
Data processing |
standard Affymetrix protocol, conducted by Penn Bioinformatics Core and Dr. John Tobias Expression level of genes in RISC-free or siYAP treated HUVEC
|
|
|
Submission date |
Oct 02, 2014 |
Last update date |
Sep 01, 2016 |
Contact name |
Zhewei Shen |
Organization name |
University of Pennsylvania
|
Lab |
Ben Stanger, M.D., Ph.D.
|
Street address |
BRB II/III Rm 527, 421 Curie Blvd.,
|
City |
Philadelphia |
State/province |
PA |
ZIP/Postal code |
19104 |
Country |
USA |
|
|
Platform ID |
GPL6244 |
Series (1) |
GSE61989 |
Expression data from HUVEC with YAP siRNA knockdown |
|
Relations |
Reanalyzed by |
GSE86357 |